XML 9 R1.htm IDEA: XBRL DOCUMENT v3.26.1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2025
Mar. 06, 2026
Jun. 30, 2025
Document Information [Line Items]      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Document Transition Report false    
Entity File Number 001-35285    
Entity Registrant Name Vaxart, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 59-1212264    
Entity Address, Address Line One 310 Utah Avenue, Suite 150    
Entity Address, City or Town South San Francisco    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94080    
City Area Code 650    
Local Phone Number 550-3500    
Title of 12(b) Security Common Stock, $0.0001 par value    
Trading Symbol VXRT    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 102,712,906
Entity Common Stock, Shares Outstanding (in shares)   240,634,372  
Amendment Description Vaxart, Inc. (the “Company,” “we,” “us,” or “our”) previously filed its Annual Report on Form 10-K for the year ended December 31, 2025 (the “Original Form 10-K”) with the Securities and Exchange Commission (the “SEC”) on March 13, 2026. In accordance with General Instruction G(3) of Form 10-K, this Amendment No. 1 to the Original Form 10-K (this “Amendment”) is being filed solely for the purpose of filing the information required by Part III of Form 10-K.    
Entity Central Index Key 0000072444    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag true